Pulmonary Histoplasmosis Mimicking Metastatic Lung Cancer: A Case Report. by Ruegg, G. et al.
diagnostics
Case Report
Pulmonary Histoplasmosis Mimicking Metastatic Lung Cancer:
A Case Report
Gion Ruegg 1,2,* , Stefan Zimmerli 3 , Maria Trachsel 1, Sabina Berezowska 4,5 , Swantje Engelbrecht 6 ,
Yonas Martin 1,† and Martin Perrig 1,†


Citation: Ruegg, G.; Zimmerli, S.;
Trachsel, M.; Berezowska, S.;
Engelbrecht, S.; Martin, Y.; Perrig, M.
Pulmonary Histoplasmosis
Mimicking Metastatic Lung Cancer:
A Case Report. Diagnostics 2021, 11,
328. https://doi.org/10.3390/
diagnostics11020328
Academic Editor: Javier Fernández
Received: 27 January 2021
Accepted: 15 February 2021
Published: 17 February 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern,
3010 Bern, Switzerland; maria.trachsel@insel.ch (M.T.); yonas.martin@insel.ch (Y.M.);
martin.perrig@insel.ch (M.P.)
2 Department of Intensive Care Medicine, University Hospital, University of Bern, 3010 Bern, Switzerland
3 Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern,
3010 Bern, Switzerland; stefan.zimmerli@insel.ch
4 Institute of Pathology, University of Bern, 3008 Bern, Switzerland; sabina.berezowska@chuv.ch
5 Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital,
University of Lausanne, 1011 Lausanne, Switzerland
6 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern,
3010 Bern, Switzerland; swantje.engelbrecht@insel.ch
* Correspondence: gionrue@gmail.com; Tel.: +41-31-632-5300; Fax: +41-31-632-1771
† Yonas Martin and Martin Perrig share last authorship.
Abstract: Histoplasmosis is a well-known endemic fungal infection but experience in non-endemic
regions is often limited, which may lead to delayed diagnosis and extensive testing. The diagnosis
can be especially challenging, typically when the disease first presents with pulmonary nodules
accompanied by hilar and mediastinal lymphadenopathy, suggesting a much more common ma-
lignant disease. In this situation, a greater FDG uptake in draining lymph nodes in comparison
with the associated lung nodule seen in [18F]FDG-PET/CT, the so-called “flip-flop fungus” sign,
can help to orientate further diagnostic measures. We report a case of a 56-year-old woman living
in Switzerland, a non-endemic region, whose diagnosis of imported histoplasmosis was delayed
since the findings had been initially misinterpreted as pulmonary malignancy. Further, histological
workup was inconclusive due to lack of specific fungal staining, leading to ineffective treatment
and non-resolving disease. This paper intends to highlight the pitfalls in diagnosing Histoplasma
capsulatum and presents images of particularities of fungal infections in [18F]FDG-PET/CT, which in
our case showed a “flip-flop fungus” sign.
Keywords: histoplasma capsulatum; PET-CT; flip-flop fungus sign; pulmonary lesion; lymphadenopa-
thy; necrotic granulomatosis
1. Introduction
We report a case of pulmonary histoplasmosis in a Swiss woman, who had travelled
to Costa Rica, a region where Histoplasma capsulatum is endemic, and in whom the initial
computed tomography scan (CT) showed a pulmonary lesion with mediastinal and hilar
lymphadenopathy compatible with pulmonary malignancy [1]. The following 2-deoxy-2-
[18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG-
PET/CT) showed a higher fluoro-D-glucose (FDG) uptake in the draining lymph nodes
than in the associated lung nodule, a so-called “flip-flop fungus” sign, first described by
Nagelschneider [2]. A following supraclavicular lymph node resection eventually led to
the diagnosis of histoplasmosis.
Histoplasmosis is a fungal infection caused by H. capsulatum complex, which is mostly
asymptomatic but can also cause severe and disseminated disease. Transmission usually
occurs through inhaled conidia or mycelial fragments from contaminated soil, where
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H. capsulatum grows best when it is enriched with bird or bat droppings [3]. Diagnostic
modalities include antigen testing, serology (immunodiffusion and complement fixation),
polymerase chain reaction assays, cultures and histopathologic studies [4–7]. Although
histoplasmosis is a common endemic disease throughout the world, its incidence in Western
Europe is very low. Recent epidemiological data from Switzerland are lacking, but a study
conducted in 1998–99 reported only four cases over these two years [8].
Since experience with H. capsulatum infections is often limited in non-endemic regions,
the disease is likely to be misdiagnosed as more common conditions, like pulmonary
malignancy, autoimmune granulomatous diseases, or mycobacterial infections. Our report
aims to share knowledge of clinical, radiological and histopathological findings in this
fungal infection to help prevent misdiagnosis.
2. Case
A 56-year-old woman consulted her general practitioner (day 0) for chest pain and
shortness of breath without fever or cough, which she had developed about three weeks
after her return (day -40) from a three-week holiday in Costa Rica. During her holidays, she
visited dusty rural areas where birds and bats were sighted, but without any close encoun-
ters with these animals. The patient was born in Switzerland, has never traveled outside of
Europe before and was an office worker without expositional hazards. Medical history was
significant for undifferentiated connective tissue syndrome, treated with hydroxychloro-
quine 200 mg/d for the past eight years, mild haemophilia type A and fatty liver disease.
Clinical examination, in particular, cardiopulmonary status, was unremarkable. Laboratory
tests revealed moderately elevated C-reactive protein (43 mg/L), elevated liver function
tests (alanine aminotransferase (ALT) 3 times, aspartate transaminase (AST) 2 times the
upper limit) and increased erythrocyte sedimentation rate (40 mm/h). The full blood count
was normal. Initial diagnostic workup ruled out an acute coronary syndrome, whereas
a CT scan of the chest (day +7) excluded pulmonary embolism but revealed a spiculated
lesion of 22 mm in diameter in the right lower lobe of the lung with right hilar and medi-
astinal lymphadenopathy, highly suspicious for malignancy. CT-guided core needle biopsy
(day +9, complicated by pneumothorax and the need for a chest tube) obtained only small
samples of the pulmonary lesion showing organizing pneumonia on histopathological
work-up. No malignant infiltrates, no bacteria and no fungi could be identified, even upon
applying special stains for infectious organisms (Grocott’s methenamine silver stain).
To further evaluate the suspected malignant disease, a [18F]FDG-PET/CT was per-
formed (day +14). It detected multiple hypermetabolic lymph nodes of up to 33 mm in
diameter, located right interlobar, at the right hilus, the mediastinum and right supraclav-
icular. The previously known lesion of the right lung showed only moderate metabolic
activity. In addition, a moderately active precaval lymph node was detected (Figure 1).
Histopathological work-up after excision of two supraclavicular lymph nodes (day +18)
revealed granulomatous lymphadenitis with necrosis. Although no pathogens could be
visualized (on Gram, Ziehl-Neelsen, Periodic Acid Shift (PAS) and Giemsa stain), the image
was considered to be most consistent with an infectious disease.
Further workup with bronchoalveolar-lavage (BAL, day +30) revealed alveolar lym-
phocytosis with a normal CD4/CD8-T-cell ratio without any growth of bacteria, mycobac-
teria (incl. M. tuberculosis after eight weeks) or fungi (after two days) in the cultures or any
histological evidence of malignant cells. Serologies were negative for Human Immunode-
ficiency Virus, Brucella spp., Coxiella burnetii, Franciscella tularensis, Bartonella henselae and
autoimmune diseases (anti-nuclear antibodies, anti-neutrophil cytoplasmic antibodies).













Figure 1. [18F]FDG-PET/CT. Upper left: PET and CT fusion images. Upper right: CT images. Lower 
left: PET images. Lower right: Maximum intensity projection. Blue line: Axial imaging level. Scale 
bars: Standardized uptake value. Star: Postinterventional diffuse uptake of the right thoracic wall 
after chest tube placement. (a) Moderate uptake in a solitary solid pulmonary lesion with irregular 
margins in the right lower lobe of the lung (b) Greater uptake in the draining lymph nodes right 
interlobar, right hilar and mediastinal (c) A further draining right supraclavicular lymph node 
showing high uptake as well (d) Moderate uptake in a precaval abdominal lymph node. 
Figure 1. [18F]FDG-PET/CT. Upper left: PET and C fusion images. Upp r right: CT images. Lower left: PET images.
Lower right: Maximum intensity projection. Blue line: Axial imaging level. Scale bars: Standardized uptake value. Star:
Postinterventional diffuse uptake of the right thoracic wall after chest tube placement. (a) Moderate uptake in a solitary
solid pulmonary lesion with irregular margins in the right lower lobe of the lung (b) Greater uptake in the draining lymph
nodes right interlobar, right hilar and mediastinal (c) A further draining right supraclavicular lymph node showing high
uptake as well (d) Moderate uptake in a precaval abdominal lymph node.
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After approximately one month of outpatient diagnostic procedures, having yielded
no evidence of malignancy or identifiable infection, autoimmune granulomatous disease
was assumed. Subsequently, an immunosuppressive treatment with high dose corticos-
teroids (prednisolone 1 mg/kg body weight daily) was initiated (day +32). After initial
improvement of the clinical symptoms, the patient deteriorated again over the next month.
This led to the patient being referred to the general internal medicine outpatient clinic at
Bern University Hospital (day +63).
Histopathological conciliary reevaluation with additional application of Grocott’s
methenamine silver stain on the resected lymph nodes detected micrometric (~5µm) ovoid
elements typical of H. capsulatum in the necrotic areas (Figure 2c), which were not visible in
the PAS stain. Although amplification of DNA for sequencing of the internal transcribed
spacer region from paraformaldehyde-fixated biopsy tissue, serology and urinary antigen
was negative for H. capsulatum (day +63), pulmonary histoplasmosis was diagnosed based
on the pathognomonic histomorphological results.
Consecutive laboratory testing revealed rising liver enzymes (ALT up to 14 times, AST
5 times, alkaline phosphatase 2 times, gamma-glutamyl transferase 15 times upper limit),
with negative serology for viral hepatitis A, B, C and E (day +65). Sonographic imaging of
the liver (day +70) was consistent with previously known liver steatosis. Further evaluation
with liver biopsy was refused by the patient.
Since first-line antifungal agents against H. capsulatum are well known for their po-
tential hepatotoxicty, and spontaneous recovery from histoplasmosis in this otherwise
immunocompetent patient was to be expected, no antifungal treatment was initiated, and
the corticosteroids were tapered down [9]. Over the next month, the patient’s symptoms
and liver function tests improved consecutively, and so she was discharged into further
care by her general practitioner (day +93) and showed no signs of a recurrent or persisting
infection after one year.
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Figure 2. Histopathological evaluation. (a): 10×. b: 2×. c: 40×., (a,b): Hematoxylin & Eosin. (c): Grocott’s methenamine silver 
stain. (a) CT-guided core needle biopsy of the pulmonary mass showing organizing pneumonia (b) Supraclavicular 
lymph-node presenting with necrotizing granulomas (c) Typical ovoid Histoplasma capsulatum yeasts stained in black and 
thus made visible using Grocott’s methenamine silver staining. 
Consecutive laboratory testing revealed rising liver enzymes (ALT up to 14 times, 
AST 5 times, alkaline phosphatase 2 times, gamma-glutamyl transferase 15 times upper 
limit), with negative serology for viral hepatitis A, B, C and E (day +65). Sonographic im-
aging of the liver (day +70) was consistent with previously known liver steatosis. Further 
evaluation with liver biopsy was refused by the patient. 
Figure 2. Histopathological evaluation. (a): 10×. (b): 2×. (c): 40×., (a,b): Hematoxylin & Eosin. (c): Grocott’s methenamine
silver stain. (a) CT-guided core needle biopsy of the pulmonary mass showing organizing pneumonia (b) Supraclavicular
lymph-node presenting with necrotizing granulomas (c) Typical ovoid Histoplasma capsulatum yeasts stained in black and
thus made visible using Grocott’s methenamine silver staining.
Diagnostics 2021, 11, 328 7 of 9
3. Discussion
Although histoplasmosis is well-known in endemic regions, it remains rare in Western
Europe and, therefore, often poses a diagnostic challenge. As presented in our case, the
radiological appearance of histoplasmosis bears resemblance to metastatic lung cancer
or autoimmune conditions, which may lead to extensive testing and/or wrong treat-
ment strategy.
Differential diagnoses of non-malignant pulmonary lesions with lymphadenopathy
include fungal infections, like histoplasmosis or coccidioidomycosis, and bacterial infec-
tions, such as tuberculosis, non-tuberculous mycobacteriosis, tularemia, melioidosis or
brucellosis. In addition, non-infectious inflammatory diseases, like sarcoidosis, granulo-
matosis with polyangiitis (Wegener’s granulomatosis), eosinophilic granulomatosis with
polyangiitis (Churg-Strauss syndrome) and pulmonary lymphomatoid granulomatosis,
are to be considered [10]. A detailed travel history with epidemiological knowledge of the
destination can substantially contribute to adapt the spectrum of differential diagnoses.
There are various diagnostic methods for histoplasmosis and the context of clinical
presentations needs to be considered. Antigen or antibody testing in urine and blood
provides the highest sensitivity during the acute phase of the disease (up to 80%). Antigen
testing generally has higher sensitivity in diffuse disease due to higher fungal burden than
in localized disease where sensitivity is only ~40%. In the latter cases, serological tests for
antibodies using both immunodiffusion and complement fixation are recommended, with
a reported sensitivity of ~90%. It is important to note that antibodies usually appear in
the second month after transmission and may be falsely negative in immunosuppressed
individuals. Culture and antigen tests from BAL fluid may help in detecting H. capsulatum
in chronic disease [11].
The diagnostic contribution of [18F]FDG-PET/CT has been demonstrated in invasive
fungal infections, especially in detecting occult foci. [18F]FDG-PET/CT is capable of
detecting increased metabolic activity, indicative of inflammatory cell activity, prior to
the onset of anatomical abnormalities detectable by conventional radiological means.
However, discriminating infection from malignancy and other inflammatory diseases
remains difficult [12–14]. In our patient, [18F]FDG-PET/CT revealed intense metabolic
activity in intrathoracic and supraclavicular lymph nodes. In contrast, the pulmonary lesion
in the right lobe displayed only moderate metabolic activity. This finding of equal or greater
FDG uptake in draining lymph node(s) in comparison with the associated lung nodule
was described by Nagelschneider as “flip-flop fungus sign” (Table 1) with a sensitivity
of 60% and specificity of 85% for benign fungal disease, predominately histoplasmosis in
a study population from an endemic area [2]. Another approach by Kadaria suggested
that dual time point [18F]FDG-PET/CT can be a helpful diagnostic tool for discriminating
between benign and malignant lesions in areas endemic for H. capsulatum [15]. The latter
radiologic technique was not used in our case. Although useful, [18F]FDG-PET/CT is not
recommended in routine diagnostics of fungal infections, mainly due to high costs and
generally low availability.
In our opinion, some aspects of the present case need to be addressed explicitly. First,
the precaval lymph node with moderately elevated FDG uptake and the concomitant
hepatitis remain unexplained but, in retrospect, could be attributed to hepatic involvement
in histoplasmosis, which may occur in immunocompetent patients on rare occasions [16].
Second, the negative serological and molecular markers in our patient may be explained
by the delay in diagnosis to a time when the infection was already resolving, the poor sen-
sitivity of these tests in non-disseminated disease and the intermittent immunosuppressive
therapy with corticosteroids. Third, the initial histopathologic evaluation of the resected
lymph nodes with Ziehl-Neelsen, PAS and Giemsa stains revealed necrotic granuloma
but failed to identify a fungal pathogen. Although certain phases of H. capsulatum can be
visualized by these stains, silver stains, such as Grocott’s methenamine silver stain, are
considered the most reliable for the detection of H. capsulatum [7,17,18]. Of note, silver
stains may be falsely negative in cases with very few fungal organisms. Fourth, the absence
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of fungal organisms in the primary CT-guided core needle biopsy of the pulmonary lesion
was most likely due to a sampling error. The finding of organizing pneumonia in the
biopsy, which often surrounds necrotic lesions, supports this assumption.
Table 1. Positive flip-flop fungus sign criteria 1.
At least one pulmonary nodule is present
Solid or part solid (not ground glass)
8–30 mm mean diameter
Not necrotic, invasive, or calcified
Any level of FDG activity data
At least one FDG-avid draining lymph node is present
SUVmax node > mediastinal blood pool
Station 11 (ipsilateral), 4 (ipsilateral) or 7
At least one draining lymph node has ≥ SUVmax than the pulmonary nodule(s)
Absence of FDG avid lesions worrisome for cancer
No obvious extrathoracic malignancy
FDG avid lesions in reticuloenthelial system (lymph nodes,
spleen, liver) permitted
1 Criteria by Nagelschneider and colleagues, Am J Nucl Med Mol Imaging 2017.
Overall, this case stresses the importance of obtaining a careful travel history in a
country where histoplasmosis is extremely rare and radiological findings can be mistaken
for more common disorders, like malignant or autoimmune diseases. It also highlights
the importance of knowledge about possible imported infectious diseases for effective
diagnostics. With this case report, we also add further images to the limited database on
[18F]FDG-PET/CT findings in patients with histoplasmosis and illustrate the potential
diagnostic value of the “flip-flop fungus sign”.
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